Ficci president Anant Goenka Tuesday said businesses have flagged concerns over current bilateral trade deal between India and Japan, which has resulted in widening of trade deficit since it was signed, and access to market here and suggested changes to regulatory and certification regime.“The other is some amount of cultural opening as well in Japan, … Read more
China has moved ahead of Elon Musk‘s ‘Jesus-level technology’ Neuralink in the race to commercialise brain-computer interface technology, approving what is being described as the world’s first commercially available brain chip after successful clinical trials.The coin-sized implant, called NEO, has become the first surgically implanted brain-computer interface (BCI) device to clear clinical testing for commercial … Read more
Reid Hoffman, the venture capitalist and co-founder of LinkedIn, has announced his departure from Microsoft’s board of directors later this year, citing a desire to dedicate his attention to a new artificial intelligence-focused drug-discovery venture. The announcement is a significant shift in Hoffman’s portfolio of responsibilities and marks the end of a seven-year tenure at … Read more
Kiran Mazumdar-Shaw, founder of Biocon, has indicated that she was preparing for a gradual leadership transition over the next five years. Her niece, Claire Mazumdar, is expected to eventually take over from her as chairperson of Biocon. Claire Mazumdar, 37 years of age, is a biotech specialist and currently heads Bicara Therapeutics as its founder … Read more
In what is one of the biggest investments in the pharma sector in India in recent years, American giant Eli Lilly and Company is injecting over $1 billion (approx Rs 8,900 crore) in setting up new contract manufacturing facilities in India over the next few years. This includes a new manufacturing and quality hub in … Read more
Generic drugmaker Natco Pharma is considering spinning off its agro business, a move for which it got an in-principle approval from the board on Thursday. The board of directors has given in-principle approval to evaluate the demerger of the agro business of the into a separate entity. The management is of the opinion that the … Read more
US President Donald Trump on Friday announced a 100% tariff on pharma products, along with 50% on kitchen cabinets and bathroom vanities, 30% on upholstered furniture and 25% on heavy trucks starting on October 1.The announcements came in a series of posts on his social media platform indicating that he remains committed to tariffs beyond … Read more
Enzeme Biosciences is a biotech subsidiary of Alkem. It has announced a new manufacturing facility in the US with an investment of $70 million. The decision also aligns with President Trump’s call asking pharma companies to boost local manufacturing and generating employment. At present, Enzene has hired 50 people and aims to take a total … Read more
It was known that Boob family is expected to sell 24% stake of the Company. In the last conference call this was discussed and management (Sikchi family) had informed that it was due to Boob family’s estate planning and not any operational concerns. Sikchi family had also committed that they are not looking to sell … Read more